Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 371 results for "sun pharma"

Closing Bell: Sensex ends on a flat note, Nifty closes above 9600; Sun Pharma gains
Money Control

Closing Bell: Sensex ends on a flat note, Nifty closes above 9...

The Sensex closed up 7.10 points at 31290.74, while the Nifty ended down 3.60 points at 9630.00. Money Control, 2 days ago
Sensex, Nifty end in the red Rediff.com, 1 week ago
[x]  

213 images for sun pharma

Money Control, 2 days ago
Money Control, 1 week ago
Money Today, 1 week ago
Money Control, 1 week ago
Business Standard, 1 week ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 3 days ago
Money Control, 2 weeks ago

Buy Asian Paints, Mamp;M, Sun Pharma, Kotak Mahindra Bank, Dabur, HUDCO: VK Sharma

VK Sharma, Head of Business, Private Client Group at HDFC Securities recommends buying Asian Paints, Mahindra and Mahindra, Sun Pharmaceutical Industries, Kotak Mahindra Bank, Dabur India and HUDCO.
 Money Control2 days ago
Sify

Sensex, Nifty end flat; Sun Pharma, SBI top gainers

Indian equities ended flat on Thursday snapping earlier losses. At the close, the 30-share benchmark index, BSE Sensex ended flat with a rise of 7.10 points or 0.02% at 31,290.74, 10 components posting rise. while the broad based NSE Nifty closed flat with a ...
 Myiris2 days ago Sensex, Nifty end flat after sluggish session  Sify3 weeks ago Sensex, Nifty post fresh closing highs; HDFC shines  Sify3 weeks ago Weekly Wrap: Sensex, Nifty record new all-time highs  Sify4 weeks ago
Money Control

Stocks in the news: Dr Reddy#39;s, Glenmark, Reliance Defence, Ramky Infra, Petronet LNG

Dr Reddy#39;s Labs | Sun Pharma | Lupin | Glenmark Pharma | Coal India | Reliance Defence | Ramky Infra | Idea Cellular | Petronet LNG | Prism Cement | Federal Bank | Godrej Consumer and Kitex Garments are stocks, which are in the news today.
 Money Control3 days ago
Money Control

Fund managers make contrarian bets on pharma stocks

Sun Pharma emerged as top choice since equity mutual funds added about 15 mn shares to portfolio
 Business Standard5 days ago Conviction Buys! Top 22 stocks where fund managers hold more than 2% in portfolio  Money Control1 week ago
Money Control

Market Live: Sensex erases gains, Nifty struggles below 9600; Sun Pharma down 2%

The broader markets marginally outperformed benchmarks, with the BSE Midcap and Smallcap indices rising 0.4 percent each.
 Money Control1 week ago Market Live: Sensex reverses gains, Nifty slips below 9150; Reliance drags  Money Control2 months ago Market Live: Sensex erases morning gains, Nifty snaps 9200; Coal India falls 2%  Money Control2 months ago Nifty cracks 1% to settle below 9,450, Sensex falls 200 points  Rediff.com1 month ago
Money Control

Buy Bharat Forge, Colgate, Federal Bank; sell Sun Pharma: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com advises buying Bharat Forge, Colgate Palmolive, Federal Bank and India Cements.
 Money Control6 days ago Sell Reliance Infra, Sun Pharma, Dish TV; buy Bharti Infratel: Ashwani Gujral  Money Control2 months ago Buy Britannia Industries, Magma Fincorp; sell Sun Pharma: Ashwani Gujral  Money Control2 months ago Buy Jubilant Life Sciences, JK Lakshmi Cement, Sun TV Network, Torrent Pharma: Ashwani Gujral  Money Control2 months ago

Indian drug firms reeling under US anti-trust row

Sun Pharma, Dr Reddy's Laboratories have also been dragged to the court by KPH Healthcare services
 Business Standard5 days ago

Indian investors ride out big-pharma slump with small-cap drugmakers

MUMBAI - Investors in Indianpharmaceutical stock, hit by quality-related sanctions againstdrugmakers operating abroad and reduced pricing power in moreprofitable markets, have adopted a new mantra: patience andpickiness. Fund managers said they are becoming ...
 Sify5 days ago
Money Control

Buy Sun Pharma; target of Rs 650: Motilal Oswal

Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 650 in its research report dated June 14, 2017.
 Money Control1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less